MARKET WIRE NEWS

Dermata Therapeutics Inc. (NASDAQ: DRMA Message Board Post 174206


Posted By: (investorshub) @subslover

Posted on: Apr/15/2025 13:18:54

Dermatas XYNGARI(TM) Phase 3 Trial Hits Statistically Significant

Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176069067


Subscribe to Our Newsletter


Message Board Posts


investorshub : US Market News
investorshub : US Market News
investorshub : glenn1919

Download The Market Wire News App

Link Market Wire News to Your X Account